Efenco’s Raising Fund

Sorainen advised Efenco on the deal. Efenco executed a raising capital. Efenco is developing a carbon-neutral combustion solution that would help use fossil fuels much more efficiently. The...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Eurowag’s Acquisition of Inelo Group

Rymarz Zdort advised the shareholders of Grupa Inelo S.A., comprising Innova Capital, European Telematics Holding and a group of individual minority shareholders on the deal. White...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Dimedium Group’s Financing Round

COBALT advised LHV Asset Management and LHV pension funds on the deal. Ellex advised Dimedium. LHV Asset Management and LHV pension funds executed a financing of the...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

WineFortune’s Investment Round

COBALT advised WineFortune on the deal. WineFortune created a fine wine investment fund  Fine wines are an alternative asset class that offers stable value growth. According to Forbes,...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Accelleron’s Spin-off from ABB

Baker McKenzie advised Skandinaviska Enskilda Banken in the deal. Accelleron executed a spin-off from ABB. Skandinaviska Enskilda Banken acted as Issuer Agent of Swedish Depositary Receipts. Accelleron...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Azelio’s Preferential Rights Offering

Baker McKenzie advised Carnegie and Pareto Securities on the offering. Vinge has advised Azelio. Azelio AB executed a a fully guaranteed preferential rights issuance of approximately SEK...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Xbrane Biopharma’s Shares Offering

Baker McKenzie advised Xbrane Biopharma on the deal. Xbrane Biopharma AB (publ) executed a primary issuance of shares of approximately SEK 170 million at a subscription price...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here